NEW YORK (Reuters Health) – Measuring both the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) when an inflammatory condition is suspected is not helpful and is possibly…
NEW YORK (Reuters Health) – Children with overactive bladder who have not responded to behavioral therapy and treatment with oxybutynin or tolterodine may be helped by treatment with…
NEW YORK (Reuters Health) – The mineral composition of kidney stones reported by commercial laboratories is often inaccurate, investigators at Indiana University, Indianapolis report in the Journal of…
NEW YORK (Reuters Health) – HER2 protein and gene expression predict the response of breast cancer patients to adjuvant trastuzumab therapy, but which test provides the best information?…
NEW YORK (Reuters Health) – The 10-year outcomes data from the MASS II trial comparing coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI) and medical treatment for…
NEW YORK (Reuters Health) – Extracorporeal shock wave lithotripsy (SWL) is safe for treating kidney stones in children, with no impact on kidney function, prospective study results suggest.…
NEW YORK (Reuters Health) – A cervical cancer prevention trial conducted in South Africa shows that a single test for human papillomavirus (HPV) infection followed by cryotherapy in…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy for a year improves cardiac size and performance in patients with mildly symptomatic heart failure, resulting in improved outcomes, according…
NEW YORK (Reuters Health) – Patients with an acute coronary syndrome referred for invasive treatment have similar outcomes whether they are given double-dose or standard-dose clopidogrel plus higher-dose…
NEW YORK (Reuters Health) – By lowering heart rate, the selective sinoatrial current inhibitor ivabradine improves outcomes in patients with chronic heart failure and an elevated heart rate,…
